ERBB2 and neoplasm: LumB—LumB tumours had a more aggressive phenotype characterised by higher genomic risk and proliferation scores, correlation coefficients to LumB, HER2-E and basal-like profile, increased expression of TP53 surrogate mutational status, HRD and differentiation.